Taxotere Hair Loss
Taxotere (docetaxel) is a chemotherapy drug approved in the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer. It is administered intravenously through a vein, and is member of a family of drugs called taxanes. It is used to try to prevent cancer cells from growing and dividing.
The Taxotere lawsuit alleges the manufacturer of Taxotere (Sanofi-Aventis) failed to warn patients and physicians of the increased risks of permanent alopecia (loss of hair) through the use of Taxotere during chemotherapy. The lawsuits state that if the manufacturer had properly warned of the risks, patients would have been prescribed a different chemotherapy drug called Taxol, which is more effective than Taxotere, and does not result in permanent hair loss.
If you or a loved one took Taxotere and suffered permanent hair loss, you may have a legal claim assistant the manufacturer. Contact the Taxotere Hair Loss lawyers at the Greensboro Law Center for a free, confidential, no obligation consultation with one of our attorneys.